Discover
XBIO
Xenetic Biosciences, Inc.
2.77
2 x 1.96
2 x 2.95
bid
ask
+
0.31
12.60%
2 @ 07:31 PM
2.68 -0.09 (3.25%)
| Ytd | 27.65% | |
| 1y | -11.22% |
2.30
day range
2.80
2.02
52 week range
10.36
| Open | 2.50 | Prev Close | 2.46 | Low | 2.30 | High | 2.80 | Mkt Cap | 6.49M |
| Vol | 415.01K | Avg Vol | 76.07K | EPS | -1.15 | P/E | N/A | Forward P/E | -6.20 |
| Beta | 2.26 | Short Ratio | 0.77 | Inst. Own | 2.10% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-15 | 50-d Avg | 3.29 | 200-d Avg | 2.85 | 1yr Est | 4.00 |
| Income Statement | |||
| Total Revenue | 660.60K | ||
| Revenues (USD) | 660.60K | ||
| Gross Profit | 660.60K | ||
| Operating Expenses | 1.63M | ||
| Research and Development Expense | 552.01K | ||
| Selling, General and Administrative Expense | 1.08M | ||
| Operating Income | -971.69K | ||
| Net Income | -929.69K | ||
| Net Income Common Stock | -929.69K | ||
| Net Income Common Stock (USD) | -929.69K | ||
| Consolidated Income | -929.69K | ||
| Earnings per Basic Share | -0.41 | ||
| Earnings per Basic Share (USD) | -0.41 | ||
| Earnings per Diluted Share | -0.41 | ||
| Earning Before Interest & Taxes (EBIT) | -929.69K | ||
| Earning Before Interest & Taxes (USD) | -929.69K | ||
| Weighted Average Shares | 2.29M | ||
| Weighted Average Shares Diluted | 2.29M | ||
| Balance Sheet | |||
| Cash and Equivalents | 6.47M | ||
| Cash and Equivalents (USD) | 6.47M | ||
| Current Assets | 6.65M | ||
| Total Assets | 6.97M | ||
| Current Liabilities | 894.98K | ||
| Total Liabilities | 894.98K | ||
| Accumulated Retained Earnings (Deficit) | -201.26M | ||
| Accumulated Other Comprehensive Income | 253.73K | ||
| Shareholders Equity | 6.07M | ||
| Shareholders Equity (USD) | 6.07M | ||
| Assets Non-Current | 313.92K | ||
| Trade and Non-Trade Payables | 322.54K | ||
| Cash Flow | |||
| Net Cash Flow / Change in Cash & Cash Equivalents | -875.49K | ||
| Net Cash Flow from Operations | -875.49K | ||
| Share Based Compensation | 51.96K | ||